Informe del mercado de la insulina humana por tipo de producto (fármacos, dispositivos de administración), canal de distribución (farmacias minoristas, farmacias hospitalarias, tiendas minoristas en línea y otros), tipo de enfermedad (diabetes tipo I, diabetes tipo II) y región 2024-2032

Informe del mercado de la insulina humana por tipo de producto (fármacos, dispositivos de administración), canal de distribución (farmacias minoristas, farmacias hospitalarias, tiendas minoristas en línea y otros), tipo de enfermedad (diabetes tipo I, diabetes tipo II) y región 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A17805

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Human Insulin Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product Type
    6.1    Drugs
        6.1.1 Market Trends
        6.1.2 Market Breakup by Type
           6.1.2.1 Human Insulin Analogs and Biosimilars
              6.1.2.1.1 Rapid Acting
                 6.1.2.1.1.1 Market Trends
                 6.1.2.1.1.2 Market Forecast
              6.1.2.1.2 Long Acting
                 6.1.2.1.2.1 Market Trends
                 6.1.2.1.2.2 Market Forecast
              6.1.2.1.3 Premixed
                 6.1.2.1.3.1 Market Trends
                 6.1.2.1.3.2 Market Forecast
           6.1.2.2 Human Insulin Biologics
              6.1.2.2.1 Short Acting
                 6.1.2.2.1.1 Market Trends
                 6.1.2.2.1.2 Market Forecast
              6.1.2.2.2 Intermediate Acting
                 6.1.2.2.2.1 Market Trends
                 6.1.2.2.2.2 Market Forecast
              6.1.2.2.3 Premixed
                 6.1.2.2.3.1 Market Trends
                 6.1.2.2.3.2 Market Forecast
        6.1.3 Market Forecast
     6.2    Delivery Devices
        6.2.1 Market Trends
        6.2.2 Market Breakup by Type
           6.2.2.1 Pens
               6.2.2.1.1 Reusable Pens
               6.2.2.1.2 Disposable Pens
           6.2.2.2 Pen Needles
               6.2.2.2.1 Standard Pen Needles
               6.2.2.2.2 Safety Pen Needles
           6.2.2.3 Syringes
           6.2.2.4 Others
        6.2.3 Market Forecast
7   Market Breakup by Distribution Channel
    7.1    Retail Pharmacies
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Hospital Pharmacies
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Online Retail Stores
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Disease Type
    8.1    Type I Diabetes
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Type II Diabetes
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Indicators
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    B. Braun Melsungen AG
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 SWOT Analysis
        14.3.2    Becton, Dickinson and Company (BD)
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio 
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Biocon
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Eli Lilly and Company
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Gulf Pharmaceutical Industries (Julphar)
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Novo Nordisk A/S
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Pfizer Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio 
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Groupe Sanofi
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio 
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    SEDICO Co.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 
        14.3.10    Wockhardt Limited
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 Financials
        14.3.11    Ypsomed AG
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio 
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis

Informe del mercado de la insulina humana por tipo de producto (fármacos, dispositivos de administración), canal de distribución (farmacias minoristas, farmacias hospitalarias, tiendas minoristas en línea y otros), tipo de enfermedad (diabetes tipo I, diabetes tipo II) y región 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials